Yousef M. Binamer
Riyadh, Saudi Arabia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Practical Saudi Guidelines on management of moderate-to-severe psoriasis: 2026 update.
Journal: The Journal of dermatological treatment
Published: September 07, 2026
The Atopic Dermatitis Shared Decision-Making Tool: Implementing the AHEAD Approach in Clinical Practice.
Journal: Journal of cutaneous medicine and surgery
Published: April 12, 2026
A Durability Index for Atopic Dermatitis: Indirect Comparison of Lebrikizumab, Dupilumab, and Tralokinumab in Maintaining Efficacy Under Variable Treatment Adherence.
Journal: Dermatology and therapy
Published: March 08, 2026
The Cost-Effectiveness and Budget Impact Analysis of Upadacitinib for Moderate-to-Severe Atopic Dermatitis in Saudi Arabia.
Journal: ClinicoEconomics and outcomes research : CEOR
Published: February 27, 2026
Letter to the Editor Regarding "Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis".
Journal: Dermatology and therapy
Published: February 13, 2026
Real-world outcomes of dupilumab therapy in moderate-to-severe atopic dermatitis patients: an observational retrospective study in Gulf countries.
Journal: The Journal of dermatological treatment
Published: November 06, 2025
Short-Term Efficacy of Lebrikizumab Versus Dupilumab in Combination with Topical Corticosteroids in Adults with Moderate-to-Severe Atopic Dermatitis: Matching-Adjusted Indirect Comparison.
Journal: Dermatology and therapy
Published: September 24, 2025
Evaluating the diagnostic accuracy of a screening questionnaire for detecting hidradenitis suppurativa: a pooled analysis of accuracy measures from the Global Hidradenitis Suppurativa Atlas (GHiSA) study.
Journal: The British journal of dermatology
Published: July 17, 2025
Achieving Optimal Treatment Targets and Minimal Disease Activity with Upadacitinib for Moderate-to-Severe Atopic Dermatitis: Integrated Analysis of Phase 3 Studies (Measure Up 1 and 2).
Journal: Dermatology and therapy
Published: June 10, 2025
Review on recommendations on the use of biologic therapy for the management of moderate-severe psoriasis in Saudi Arabia: an expert opinion.
Journal: Expert opinion on biological therapy
Published: April 21, 2025
Impact of Achieving Optimal Treatment Targets and Minimal Disease Activity on Health-Related Quality of Life and Satisfaction in Patients with Atopic Dermatitis.
Journal: Dermatology and therapy
Published: April 18, 2025
Last Updated: 09/26/2026